Stock Rich List
#6090 on the rich list of 14,644 insiders

Steve Krognes

Director at Denali Therapeutics; Director at Guardant Health. Based in Palo Alto, California.

$16.1M
in disclosed stock, −$160K (−0.99%) today
Market closed. Prices as of Nov 19, 4:00 PM ET
Rank
6090th of 14,644
Companies held
2
Largest holding
DNLI, 92.8% of total
Latest SEC filing
Sep 16, 2026

What the $16.1M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Denali Therapeutics DNLI
Common Stock
Through Steve Edward Krognes Revocable Trust781,797$18.20$14.2M88.5%Form 4, Jun 3, 2026
Guardant Health GH
Common Stock
Directly7,906$145.59$1.2M7.2%Form 4, Sep 16, 2026
Denali Therapeutics DNLI
Common Stock
Directly38,202$18.20$695K4.3%Form 4, Jun 3, 2026

Share counts are the amounts Steve Krognes reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Sep 16, 2026SoldGH1,103$174.46$192KView
Sep 16, 2026SoldGH971$177.48$172KView
Sep 16, 2026SoldGH1,300$176.34$229KView
Sep 16, 2026SoldGH3,300$175.42$579KView
Jun 4, 2026SoldGH9,294$132.51$1.2MView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
6087Marlene Debel
EVP & Chief Risk Officer, MetLife. New York, NY
$16.1M−$353K (−2.15%)
6088Calvin Butler Jr
President & CEO, Exelon. St. Louis, MO
$16.1M−$198K (−1.21%)
6089Robert F. Cummings Jr.
Director, Corning. Corning, NY
$16.1M−$326K (−1.99%)
6090Steve Krognes
Director, Denali Therapeutics. Palo Alto, CA
$16.1M−$160K (−0.99%)
6091Ronald L. Olson
Director, Berkshire Hathaway. San Francisco, CA
$16.1M−$97K (−0.60%)
6092Nicholas Earl
Director, Powerlaw. San Francisco, CA
$16.1M−$450K (−2.72%)
6093Jose E. Almeida
Chairman, CEO, President, Baxter International. Charlotte, NC
$16.1M−$455K (−2.76%)

Other Denali Therapeutics insiders

All DNLI insiders

Questions

How much stock does Steve Krognes own?

Steve Krognes holds $16,075,016 in listed stock based on SEC filings and current prices, mostly Denali Therapeutics (DNLI). That ranks 6090th on the Stock Rich List.

Is this Steve Krognes's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Steve Krognes last buy or sell stock?

The most recent open-market trade on file is a sale of 1,103 GH shares on Sep 16, 2026 at $174.46.